Prostate Cancer Predictive Simulation Modelling, Assessing the Risk Technique (PCP-SMART): Introduction and Initial...

Area of Science:

• Urology
• Oncology
• Medical Diagnostics

Background:

• Prostate cancer (PCa) detection relies on accurate risk assessment before biopsy.
• Existing predictors for PCa risk have limitations in precision.

Purpose of the Study:

• To develop and validate a novel predictive model for estimating the probability of PCa on prostate biopsy.
• Introduce the Prostate Cancer Risk Determinator (PCRD) index and a PCa risk equation.

Main Methods:

• Developed a mathematical model (PCP-SMART) using data from 371 men undergoing prostate biopsy.
• Utilized linear regression to derive the PCRD index based on ratios of total PSA (tPSA), age, prostate volume, and free PSA (fPSA).
• Validated the PCRD index using chi-squared tests, logistic regression, and ROC analysis.

Main Results:

• The PCRD index demonstrated high accuracy, with 89.8% sensitivity and 91.5% specificity for PCa detection.
• The PCRD index significantly outperformed established PCa predictors (Area Under the Curve = 0.926).
• The formulated risk equation achieved 91% accuracy in predicting individual PCa probability.

Conclusions:

• The PCRD index is a reliable and independent predictor of prostate biopsy outcomes.
• This novel tool accurately estimates individual PCa risk, improving diagnostic decisions.
• The PCRD index offers a significant advancement over existing methods for PCa risk assessment.